AHCO

AdaptHealth Corp (AHCO) | Rumor.io

AdaptHealth

AHCO

Attention (50-day avg)0%

Attention rank (50-day avg)#3,194

Bullish sentiment (50-day avg)66%

Price to earnings ratio16.6

Market capitalization768.7M

Earnings per share-1.71

Dividend yield (TTM)—

Revenue (annual)3.2B

Net income (annual)-66M

Social

What share of all stock conversation is about AHCO?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% 0	0% 0	0% 0	0% 0

Aug 11

AdaptHealth Corp.'s (AHCO) CEO faces criticism for losing control and allowing a single supplier to take a billion dollars from shareholders' market capitalization.
Directors Kenneth A. Samet and Dale B. Wolf have recently purchased $150,000 and $245,000 worth of AHCO shares, respectively, amidst the company's strategic shift to focus on core sleep and respiratory equipment business.
AHCO is selling its diabetes management unit to refocus operations on higher-growth segments, marking a strategic shift to streamline the company's portfolio.

Generated by AI

Sentiment

Of the messages about AHCO that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	—	—	83.33% +20.32	83.16% +17.59
Bearish	—	—	16.67% -20.32	16.84% -17.59

Bullish· Apr 13

$AHCO is a screaming buy opportunity due to the dismissal of a co-CEO being unrelated to the company's operations and other solid management being in place.
The company's tax issues were a personal matter of the CEO, unrelated to the business, and the stock price has overreacted, presenting a buying opportunity.
$AHCO has been consistently growing revenue every quarter, making it a gift to buy at current prices, with a strong potential for long-term gains.

Bearish· Apr 13

The co-CEO of AdaptHealth Corp. ($AHCO) has been charged with tax fraud in Denmark, an issue unrelated to the company, and is currently on unpaid leave.
The stock price of $AHCO has dropped significantly, with a 20% decline, due to the unrelated personal issue of the co-CEO.
The market's reaction to the personal issue of the co-CEO may be an overreaction, as the company's fundamentals have not changed, and the stock may be a buying opportunity.

Generated by AI

Topics

Of the messages about AHCO that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Technical Analysis	—	—	61.54%	14.76%
Announcements	—	—	23.08%	11.28%
Earnings	—	—	0%	19.44%
Analysts	—	—	0%	25.87%
Macro	—	—	15.38%	28.65%
Controversies	—	—	0%	0%

May 9

AdaptHealth Corp. (AHCO) announced its first quarter 2023 results, with net revenue increasing 5.4% to $744.6 million and net income attributable to AdaptHealth Corp. at $15.7 million.
Stephen Griggs, AHCO's Chief Executive Officer, will step down by mutual agreement with the Board of Directors, effective June 30, 2023.
AHCO's adjusted EBITDA decreased 2.7% to $134.0 million in the first quarter of 2023, compared to $137.6 million in the same period last year.

Generated by AI

Community

Of the messages about AHCO, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	—	—	8.33%	16%
Newcomers	—	—	91.67%	84%

Regulars· May 9

AdaptHealth Corp. reports Q4 results, misses on revenue and guides FY23 revenue below consensus, with AHCO stock price down 3% to $12.07.
AdaptHealth CEO Stephen Griggs will step down by mutual agreement, with no clear reason given for his departure.
AdaptHealth Corp. reports Q1 2023 results, with earnings of $0.01 per share, missing the consensus estimate of $0.08.

Newcomers· Aug 11

The recent insider buying activity by AdaptHealth Corp. directors Dale B. Wolf and Kenneth A. Samet, with Wolf purchasing $245K worth of shares and Samet buying $150K, is seen as a positive signal for the stock.
The company's CEO is under scrutiny for her handling of the business, including a 30% price increase and the cost of administering business to a new client base, with some users expressing skepticism about her ability to turn the company around.
AdaptHealth Corp. has announced plans to sell its diabetes management unit to focus on its core sleep and respiratory equipment business, marking a strategic shift to streamline the company's portfolio and prioritize higher-growth segments.

Generated by AI

PLYMOUTH MEETING, Pa., September 11, 2026--AdaptHealth Corp. (NASDAQ: AHCO) ("AdaptHealth" or the "Company"), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, announced today announced today that they will participate in the following upcoming investor conferences:

18d agoYahoo Finance

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Zimmer Biomet Holdings (ZBH), AdaptHealth (AHCO) and Pharvaris (PHVS)

Detailed price information for Zimmer Biomet Holdings (ZBH-N) from The Globe and Mail including charting and trades.

20d agotheglobeandmail.com

Why AdaptHealth (AHCO) Stock Is Down Today

Shares of healthcare services provider AdaptHealth Corp. (NASDAQ:AHCO) fell 8.6% in the afternoon session after the company announced the appointment of Harriss T. Currie as Chief Financial Officer, taking over duties from Jason Clemens.

20d agoYahoo Finance UK

Truist reiterates Buy on AdaptHealth stock after CFO change

20d agoInvesting.com

AdaptHealth appoints new chief financial officer Currie

Detailed price information for Adapthealth Corp Cl. A (AHCO-Q) from The Globe and Mail including charting and trades.

21d agoThe Globe and Mail

Also Discussed

Investors talking about AHCO also mention

#	Name	Attention
1	Smith Douglas Homes CorporationSDHC	0%0
2	Hagerty, Inc.HGTY	0%new
3	Transcontinental Realty Investors, Inc.TCI	0%0
4	OSH - Oak Street Health, Inc.	——
5	Repay Holdings Corporation Class A Common StockRPAY	0%0
6	AMED - Amedisys, Inc.	——
7	Dentsply Sirona Inc.XRAY	0%new
8	TTEC Holdings, Inc.TTEC	0%0
9	OptimizeRx CorporationOPRX	0%0
10	Universal Electronics Inc.UEIC	0%0

AdaptHealth Corp

Healthcare
Medical Devices

AdaptHealth Corp. is a healthcare services company that provides home medical equipment, medical supplies, and related patient support services across the United States. The company focuses on care delivered outside the hospital through offerings in sleep health, respiratory health, diabetes health, and wellness at home. Its products and services include sleep therapy equipment, oxygen and ventilation systems, continuous glucose monitors, insulin pumps, and a broad range of durable medical equipment used in chronic and post-acute care. AdaptHealth works with Medicare, Medicaid, and commercial insurance patients, serving individuals who need recurring medical support in the home. The company plays an important role in the healthcare-at-home market by helping patients manage ongoing conditions with equipment, supplies, and service coordination tailored to home-based care.

Website

Location

555 East North Lane

Conshohocken, PA, 19428

United States

Social

What share of all stock conversation is about AHCO?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% 0	0% 0	0% 0	0% 0

Aug 11

AdaptHealth Corp.'s (AHCO) CEO faces criticism for losing control and allowing a single supplier to take a billion dollars from shareholders' market capitalization.
Directors Kenneth A. Samet and Dale B. Wolf have recently purchased $150,000 and $245,000 worth of AHCO shares, respectively, amidst the company's strategic shift to focus on core sleep and respiratory equipment business.
AHCO is selling its diabetes management unit to refocus operations on higher-growth segments, marking a strategic shift to streamline the company's portfolio.

Generated by AI

Sentiment

Of the messages about AHCO that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	—	—	83.33% +20.32	83.16% +17.59
Bearish	—	—	16.67% -20.32	16.84% -17.59

Bullish· Apr 13

$AHCO is a screaming buy opportunity due to the dismissal of a co-CEO being unrelated to the company's operations and other solid management being in place.
The company's tax issues were a personal matter of the CEO, unrelated to the business, and the stock price has overreacted, presenting a buying opportunity.
$AHCO has been consistently growing revenue every quarter, making it a gift to buy at current prices, with a strong potential for long-term gains.

Bearish· Apr 13

The co-CEO of AdaptHealth Corp. ($AHCO) has been charged with tax fraud in Denmark, an issue unrelated to the company, and is currently on unpaid leave.
The stock price of $AHCO has dropped significantly, with a 20% decline, due to the unrelated personal issue of the co-CEO.
The market's reaction to the personal issue of the co-CEO may be an overreaction, as the company's fundamentals have not changed, and the stock may be a buying opportunity.

Generated by AI

Topics

Of the messages about AHCO that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Technical Analysis	—	—	61.54%	14.76%
Announcements	—	—	23.08%	11.28%
Earnings	—	—	0%	19.44%
Analysts	—	—	0%	25.87%
Macro	—	—	15.38%	28.65%
Controversies	—	—	0%	0%

May 9

AdaptHealth Corp. (AHCO) announced its first quarter 2023 results, with net revenue increasing 5.4% to $744.6 million and net income attributable to AdaptHealth Corp. at $15.7 million.
Stephen Griggs, AHCO's Chief Executive Officer, will step down by mutual agreement with the Board of Directors, effective June 30, 2023.
AHCO's adjusted EBITDA decreased 2.7% to $134.0 million in the first quarter of 2023, compared to $137.6 million in the same period last year.

Generated by AI

Community

Of the messages about AHCO, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	—	—	8.33%	16%
Newcomers	—	—	91.67%	84%

Regulars· May 9

AdaptHealth Corp. reports Q4 results, misses on revenue and guides FY23 revenue below consensus, with AHCO stock price down 3% to $12.07.
AdaptHealth CEO Stephen Griggs will step down by mutual agreement, with no clear reason given for his departure.
AdaptHealth Corp. reports Q1 2023 results, with earnings of $0.01 per share, missing the consensus estimate of $0.08.

Newcomers· Aug 11

The recent insider buying activity by AdaptHealth Corp. directors Dale B. Wolf and Kenneth A. Samet, with Wolf purchasing $245K worth of shares and Samet buying $150K, is seen as a positive signal for the stock.
The company's CEO is under scrutiny for her handling of the business, including a 30% price increase and the cost of administering business to a new client base, with some users expressing skepticism about her ability to turn the company around.
AdaptHealth Corp. has announced plans to sell its diabetes management unit to focus on its core sleep and respiratory equipment business, marking a strategic shift to streamline the company's portfolio and prioritize higher-growth segments.

Generated by AI

AdaptHealth

Social

Aug 11

Sentiment

Bullish· Apr 13

Bearish· Apr 13

Topics

May 9

Community

Regulars· May 9

Newcomers· Aug 11

News

AdaptHealth at Jefferies conference: focus shifts to scale and capitation

AdaptHealth To Participate in Upcoming Investor Conferences

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Zimmer Biomet Holdings (ZBH), AdaptHealth (AHCO) and Pharvaris (PHVS)

Why AdaptHealth (AHCO) Stock Is Down Today

Truist reiterates Buy on AdaptHealth stock after CFO change

AdaptHealth appoints new chief financial officer Currie

Also Discussed

AdaptHealth Corp

Company Information

Location

News

AdaptHealth at Jefferies conference: focus shifts to scale and capitation

AdaptHealth To Participate in Upcoming Investor Conferences

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Zimmer Biomet Holdings (ZBH), AdaptHealth (AHCO) and Pharvaris (PHVS)

Why AdaptHealth (AHCO) Stock Is Down Today

Truist reiterates Buy on AdaptHealth stock after CFO change

AdaptHealth appoints new chief financial officer Currie

Also Discussed

Social

Aug 11

Sentiment

Bullish· Apr 13

Bearish· Apr 13

Topics

May 9

Community

Regulars· May 9

Newcomers· Aug 11